During a recent analyst briefing titled “From Stem Cells and Cancer to Diagnostics and Therapeutics; microRNAs-Small Molecules with a Big Impact” Frost & Sullivan presented data about the US miRNA market. According to these data the qRT-PCR segment represents the largest segment in the overall miRNA market (37.7%). It is followed by the microarray segment which accounts for 30.4%.
Considering the importance of qRT-PCR in our field the following conference announcement might be of interest:
qPCR Congress 2009 (www.qpcr-congress.com), is to be held on the 16th & 17th November in London. The congress is the single most focused event in Europe dedicated to key technological and scientific trends & advances in qPCR in the pharmaceutical and biotech industry, as well as academic institutions. Over two days, the organizers expect over 120 senior-level decision makers working in discovery, biomarkers, gene expression, molecular biology, and clinical & diagnostics development and bioinformatics & data management from the UK, Europe and US. For more information please contact [email protected]